Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Ken Charhut
AddedMar 31, 2024
UpdatedMay 31, 2026
Ken Charhut

Ken Charhut

Board Member, Summation Health Ventures

CrunchbaseLinkedIn

Ken Charhut's Career

Summation Health Ventures
Summation Health Ventures

Long Beach, CA, US

Board Member· Board
Memorialcare Innovation Fund
Memorialcare Innovation Fund

Long Beach, CA, US

Board Member· Board
ReShape Medical
ReShape Medical

San Clemente, CA, US

Board Member· Board
Foldax
Foldax

Salt Lake City, UT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Ken Charhut's Career

Summation Health Ventures
Summation Health Ventures
Fund72014Long Beach, CA, US
Board Member· Board

Leadership at Summation Health Ventures

Thomas PriselacThomas PriselacBoard Member
Brant HeiseBrant HeiseBoard Member
Helen MacfieHelen MacfieBoard Member
Scott JoslynScott JoslynBoard Member
Barry ArbuckleBarry ArbuckleBoard Member
Darren DworkinDarren DworkinBoard Member
Memorialcare Innovation Fund
Memorialcare Innovation Fund
Investment FirmInvestment Firm301993Long Beach, CA, US
Board Member· Board
ReShape Medical
ReShape Medical
Series A$69M302005San Clemente, CA, US
Board Member· Board

Leadership at ReShape Medical

David MilneDavid MilneBoard Member
Casey TanseyCasey TanseyBoard Member
Robert Edward GrantRobert Edward GrantBoard Member
Andrew CraggAndrew CraggFounder
John LehmannJohn LehmannBoard Member
Michael MashaalMichael MashaalBoard Member

Similar to ReShape Medical

Aspire BariatricsAspire BariatricsKing of Prussia, PA, USMedical Devices, Weight Lossest. 2004Aspire BariatricsKing of Prussia, PA, US · est. 2004

Aspire Bariatrics: Providing minimally-invasive, reversible weight loss solutions.

Series A · $25.2M30
EndoshapeEndoshapeBoulder, CO, USMedical Devicesest. 2006EndoshapeBoulder, CO, US · est. 2006

EndoShape, Inc., a Boulder-based company, innovates medical devices like invasive plugs, coils, and polymer-based tools for blood vessel occlusion.

Series A · $30.8M30
Medical Body SculptingMedical Body SculptingVienna, VA, USBody Sculpting, Fat Removalest. 2006Medical Body SculptingVienna, VA, US · est. 2006

MedSculpt, a network of physician-owned centers, offers high-quality, non-surgical fat removal treatments with expert operational and marketing support from Medical Body Sculpting, Inc.

Angel · $6.1M5
Foldax
Foldax
Series A$43.4M402013Salt Lake City, UT, US
Board Member· Board

Leadership at Foldax

Scott HuennekensScott HuennekensBoard Member
Gregory CasciaroGregory CasciaroCEO
Jim DemetriadesJim DemetriadesBoard Member
Frank MaguireFrank MaguireFounder

Ken Charhut's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Ken Charhut

Kris JohnsonKris JohnsonBoard Member · Aphelion CapitalScott GlennScott GlennFounder · Windamere Venture PartnersPeter BentonPeter BentonBoard Member · Flexible Medical SystemsNiles NoblittNiles NoblittBoard Member · Rose-Hulman Institute of TechnologyAlice SchroederAlice SchroederBoard Member · RefleXion MedicalJack W. LasersohnJack W. LasersohnBoard Member · Silk Road Medical